Johnson & Johnson (JNJ) Research & Development (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Research & Development data on file, last reported at $3.5 billion in Q1 2026.

• Quarterly Research & Development rose 9.36% year-over-year to $3.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $411.0 million (down 97.57% YoY) and the FY2025 annual result came in at $109.0 million, down 99.37% from the prior year.
• Research & Development grew to $3.5 billion in Q1 2026 per JNJ's latest filing, from -$10.3 billion in the prior quarter.
• The five-year high for Research & Development was $6.2 billion in Q1 2022, with the low at -$10.3 billion in Q4 2025.
• Average Research & Development over 5 years is $2.3 billion, with a median of $3.5 billion recorded in 2025.
• Year-over-year, Research & Development tumbled 344.43% in 2023 and surged 152.34% in 2024.
• Johnson & Johnson's Research & Development stood at $3.5 billion in 2022, then sank by 390.44% to -$10.1 billion in 2023, then surged by 152.34% to $5.3 billion in 2024, then tumbled by 294.49% to -$10.3 billion in 2025, then surged by 134.23% to $3.5 billion in 2026.
• Business Quant data shows JNJ's Research & Development at $3.5 billion in Q1 2026, -$10.3 billion in Q4 2025, and $3.7 billion in Q3 2025.